You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ambrisentan

Showing 1 - 25 of 83
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 1 Diabetes With Diabetic Nephropathy Trial in Worldwide (Sotagliflozin, Ambrisentan, Ambrisentan and Sotagliflozin)

Not yet recruiting
  • Type 1 Diabetes Mellitus With Diabetic Nephropathy
  • Aurora, Colorado
  • +6 more
Oct 2, 2023

Pulmonary Arterial Hypertension Trial in Shanghai (Ambrisentan)

Completed
  • Pulmonary Arterial Hypertension
  • Ambrisentan
  • Shanghai, China
    Renji Hospital
Jun 28, 2022

Exercise-induced Pulmonary Arterial Hypertension Trial in Boston (Ambrisentan)

Completed
Has Results
  • Exercise-induced Pulmonary Arterial Hypertension
  • Ambrisentan
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jan 5, 2022

Pulmonary Arterial Hypertension Trial (Ambrisentan, Placebo)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • Ambrisentan
  • Placebo
  • (no location specified)
Jul 13, 2021

Hypertension, Pulmonary Trial in Worldwide (Ambrisentan)

Active, not recruiting
  • Hypertension, Pulmonary
  • Ambrisentan
  • Aurora, Colorado
  • +21 more
Apr 7, 2022

Covid19, Hypoxemia Trial in Spain (Ambrisentan, Placebo)

Recruiting
  • Covid19
  • Hypoxemia
  • Ambrisentan
  • Placebo
  • Gijón, Asturias, Spain
  • +10 more
Aug 4, 2021

Pre-Pulmonary Atrial Hypertension Trial in Denver (Ambrisentan)

Terminated
  • Pre-Pulmonary Atrial Hypertension
  • Ambrisentan
  • Denver, Colorado
    National Jewish Health
Jan 15, 2021

Portopulmonary Hypertension Trial in United States (Ambrisentan)

Completed
Has Results
  • Portopulmonary Hypertension
  • Ambrisentan
  • La Jolla, California
  • +5 more
Dec 16, 2020

VOLIBRIS® (Ambrisentan) (Pulmonary Arterial Hypertension)

Completed
  • Hypertension, Pulmonary
  • Ambrisentan
  • (no location specified)
Sep 2, 2020

Pharmacogenomics in Pulmonary Arterial Hypertension

Withdrawn
  • Pulmonary Arterial Hypertension
  • +2 more
  • Pittsburgh, Pennsylvania
    Allegheny General Hospital
Nov 29, 2021

Systemic Sclerosis, Shortness of Breath, Pulmonary Hypertension Trial in Los Angeles (Ambrisentan)

Completed
Has Results
  • Systemic Sclerosis
  • +2 more
  • Ambrisentan
  • Los Angeles, California
    David Geffen School of Medicine, University of California, Los A
Oct 28, 2020

Cirrhosis, Portal Hypertension, Ascites Trial in Barcelona, Majadahonda, Madrid (Ambrisentan)

Terminated
  • Cirrhosis
  • +2 more
  • Ambrisentan
  • Barcelona, Catalunya, Spain
  • +5 more
Feb 23, 2021

Metabolic Syndrome X Trial in Madison (drug, device, other)

Completed
  • Metabolic Syndrome X
  • NOS Inhibition
  • +6 more
  • Madison, Wisconsin
    University of Wisconsin, Madison
Oct 14, 2021

COVID-19 Trial in Cambridge (EDP1815, Dapagliflozin, Ambrisentan)

Recruiting
  • COVID-19
  • Cambridge, Cambridgeshire, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust
Jun 9, 2021

Hypertension, Pulmonary Trial in Cambridge (AMB new formulation (1 mg), Reference AMB (5 mg))

Completed
Has Results
  • Hypertension, Pulmonary
  • AMB new formulation (1 mg)
  • Reference AMB (5 mg)
  • Cambridge, Cambridgeshire, United Kingdom
    GSK Investigational Site
Jul 21, 2020

Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction Trial in Dallas (Ambrisentan, Placebo)

Terminated
Has Results
  • Pulmonary Hypertension
  • Heart Failure With Preserved Ejection Fraction
  • Ambrisentan
  • Placebo
  • Dallas, Texas
    UT Southwestern Medical Center
May 15, 2020

Pulmonary Arterial Hypertension Trial in Shanghai (Sulfasalazine, Ambrisentan, Sulfasalazine's )

Recruiting
  • Pulmonary Arterial Hypertension
  • Shanghai, China
    Renji Hospital
Aug 22, 2020

Pulmonary Hypertension Trial in Calgary, Vancouver (Riociguat Oral Product)

Unknown status
  • Pulmonary Hypertension
  • Riociguat Oral Product
  • Calgary, Alberta, Canada
  • +1 more
Mar 24, 2020

Pulmonary Arterial Hypertension Trial in Boston (Ambrisentan plus Spironolactone, Ambrisentan plus Placebo)

Terminated
Has Results
  • Pulmonary Arterial Hypertension
  • Ambrisentan plus Spironolactone
  • Ambrisentan plus Placebo
  • Boston, Massachusetts
    Brigham & Women's Hospital
Nov 13, 2019

Sickle Cell Anemia Trial in Augusta (Ambrisentan, Placebo)

Completed
  • Sickle Cell Anemia
  • Ambrisentan
  • Placebo
  • Augusta, Georgia
    Augusta University
Apr 1, 2020

Pulmonary Hypertension Trial in Worldwide (Ambrisentan)

Completed
Has Results
  • Pulmonary Hypertension
  • Ambrisentan
  • Birmingham, Alabama
  • +45 more
Sep 8, 2020

Kidney Failure, Acute Trial in Haifa (Ambrisentan 10 MG)

Unknown status
  • Kidney Failure, Acute
  • Ambrisentan 10 MG
  • Haifa, Israel
  • +1 more
Jun 24, 2020

Hypoplastic Left Heart Syndrome, Hypoplastic Right-sided Heart Complex Trial in Durham (Ambrisentan, Placebo)

Completed
Has Results
  • Hypoplastic Left Heart Syndrome
  • Hypoplastic Right-sided Heart Complex
  • Ambrisentan
  • Placebo
  • Durham, North Carolina
    Duke Universtiy Hospital
Aug 20, 2019

Systemic Sclerosis, Pulmonary Hypertension Trial in Heidelberg (Ambrisentan, Placebo)

Completed
Has Results
  • Systemic Sclerosis
  • Pulmonary Hypertension
  • Ambrisentan
  • Placebo
  • Heidelberg, Germany
    Thoraxclinic at the University of Heidelberg
Apr 17, 2020

Hypertension, Pulmonary Trial in Worldwide (Ambrisentan - low dose, Ambrisentan - high dose)

Terminated
Has Results
  • Hypertension, Pulmonary
  • Ambrisentan - low dose
  • Ambrisentan - high dose
  • Aurora, Colorado
  • +23 more
Sep 19, 2019